{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "currency": "EUR", "market": "gb_market", "esgPopulated": false, "gmtOffSetMilliseconds": 3600000, "exchange": "IOB", "longName": "Pharming Group N.V.", "shortName": "PHARMING GROUP NV PHARMING GROU", "regularMarketPrice": 1.08, "regularMarketChangePercent": 6.7193756, "marketState": "CLOSED", "fiftyTwoWeekHighChangePercent": -0.23674907, "fiftyTwoWeekLow": 0.664, "fiftyTwoWeekHigh": 1.415, "trailingAnnualDividendRate": 0.0, "trailingPE": 54.000004, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 0.41600007, "fiftyTwoWeekLowChangePercent": 0.62650615, "fiftyTwoWeekRange": "0.664 - 1.415", "fiftyTwoWeekHighChange": -0.33499992, "epsTrailingTwelveMonths": 0.02, "sharesOutstanding": 656348032, "bookValue": 0.312, "fiftyDayAverage": 1.072845, "fiftyDayAverageChange": 0.007155061, "fiftyDayAverageChangePercent": 0.00666924, "twoHundredDayAverage": 1.11253, "twoHundredDayAverageChange": -0.03252995, "twoHundredDayAverageChangePercent": -0.029239615, "marketCap": 708855872, "priceToBook": 3.4615386, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1218006000000, "priceHint": 4, "regularMarketChange": 0.06800008, "regularMarketTime": 1683910728, "regularMarketDayHigh": 1.085, "regularMarketDayRange": "1.021 - 1.085", "regularMarketDayLow": 1.021, "regularMarketVolume": 2929252, "regularMarketPreviousClose": 1.012, "bid": 1.038, "ask": 1.107, "bidSize": 0, "askSize": 0, "fullExchangeName": "IOB", "financialCurrency": "USD", "regularMarketOpen": 1.027, "averageDailyVolume3Month": 1859112, "averageDailyVolume10Day": 1766585, "symbol": "0QCO.IL"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Darwinweg 24", "city": "Leiden", "zip": "2333 CR", "country": "Netherlands", "phone": "31 71 524 7400", "fax": "31 71 524 7445", "website": "https://www.pharming.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.", "fullTimeEmployees": 332, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sijmen  de Vries M.B.A., M.D., MBA", "age": 63, "title": "Pres, CEO & Exec. Director", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 1176000, "fmt": "1.18M", "longFmt": "1,176,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jeroen  Wakkerman", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Mireille  Sanders M.Sc.", "age": 54, "title": "Chief Operations Officer", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Susanne  Embleton", "title": "Investor Relations Mang.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ruud  Van Outersterp", "age": 58, "title": "Chief Ethics & Compliance Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Anurag  Relan M.D., MPH", "age": 50, "title": "Chief Medical Officer", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Stephen  Toor", "age": 51, "title": "Chief Commercial Officer & GM Americas", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Bruno M. L. Giannetti", "age": 70, "title": "Consultant", "yearBorn": 1952, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 7, "boardRisk": 3, "compensationRisk": 6, "shareHolderRightsRisk": 4, "overallRisk": 4, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}